1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow HIV Primary Infection: new trials by email Literature Review of HIV Primary Infection trials Research Report on HIV Primary Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection 50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide - HIV Primary Infection | Phase 2 | Unknown | Anna Cruceta | 66 | 2020-12-04 | 2021-07-19 |
Acquired Immunodeficiency Syndrome (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · RNA Virus Infections (1) · Retroviridae Infections (1) · Sexually Transmitted Diseases (1) · Sexually Transmitted Diseases, Viral (1) · Slow Virus Diseases (1) · Urogenital Diseases (1) · Virus Diseases (1)
bictegravir (1) · bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)
Anna Cruceta (1)
Spain (1)